Inhibition of UGT1A1 by natural and synthetic flavonoids.
暂无分享,去创建一个
Ping Wang | Xia Lv | Guang-Bo Ge | Yun-Feng Cao | Moshe Finel | M. Finel | Guangbo Ge | Yun-feng Cao | Xin-Yu Liu | Chun-Zhi Ai | Qi-Hang Zhou | Bin Fan | Hui Tang | X. Lv | Hui Tang | Chunzhi Ai | Qi-Hang Zhou | Ping Wang | Xin-Yu Liu | Bin Fan
[1] Tanaka, , 2020, Catalysis from A to Z.
[2] J. Chen,et al. Nevadensin is a naturally occurring selective inhibitor of human carboxylesterase 1. , 2018, International journal of biological macromolecules.
[3] Guangbo Ge,et al. Biflavones from Ginkgo biloba as novel pancreatic lipase inhibitors: Inhibition potentials and mechanism. , 2018, International journal of biological macromolecules.
[4] Ye Qi,et al. Inhibitory mechanism and molecular analysis of furoic acid and oxalic acid on lipase. , 2018, International journal of biological macromolecules.
[5] Tongyi Dou,et al. Chemical Probes for Human UDP‐Glucuronosyltransferases: A Comprehensive Review , 2018, Biotechnology journal.
[6] M. Finel,et al. Recent progress and challenges in screening and characterization of UGT1A1 inhibitors , 2018, Acta pharmaceutica Sinica. B.
[7] M. Anese,et al. Effect of coffee roasting on in vitro α-glucosidase activity: Inhibition and mechanism of action. , 2018, Food research international.
[8] Guangbo Ge,et al. Amentoflavone is a potent broad-spectrum inhibitor of human UDP-glucuronosyltransferases. , 2018, Chemico-biological interactions.
[9] Guangbo Ge,et al. A Practical and High-Affinity Fluorescent Probe for Uridine Diphosphate Glucuronosyltransferase 1A1: A Good Surrogate for Bilirubin. , 2017, Journal of medicinal chemistry.
[10] Tongyi Dou,et al. Structure-activity relationships of flavonoids as natural inhibitors against E. coli β-glucuronidase. , 2017, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[11] Guangbo Ge,et al. Comparison of the inhibition potentials of icotinib and erlotinib against human UDP-glucuronosyltransferase 1A1 , 2017, Acta pharmaceutica Sinica. B.
[12] Jianbo Xiao,et al. Flavonoids as modulators of metabolic enzymes and drug transporters , 2017, Annals of the New York Academy of Sciences.
[13] Ying Xie,et al. Role of UDP-Glucuronosyltransferase 1A1 in the Metabolism and Pharmacokinetics of Silymarin Flavonolignans in Patients with HCV and NAFLD , 2017, Molecules.
[14] B. Yan,et al. Vitexin attenuates acute doxorubicin cardiotoxicity in rats via the suppression of oxidative stress, inflammation and apoptosis and the activation of FOXO3a. , 2016, Experimental and therapeutic medicine.
[15] Hongbing Wang,et al. Insights into CYP2B6-mediated drug–drug interactions , 2016, Acta pharmaceutica Sinica. B.
[16] Guangbo Ge,et al. Comparison of the inhibitory effects of tolcapone and entacapone against human UDP-glucuronosyltransferases. , 2016, Toxicology and applied pharmacology.
[17] Guangbo Ge,et al. Assessment of the inhibition potential of Licochalcone A against human UDP-glucuronosyltransferases. , 2016, Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association.
[18] B. Goh,et al. UGT1A1 Mediated Drug Interactions and its Clinical Relevance. , 2016, Current drug metabolism.
[19] R. Tukey,et al. Role of extrahepatic UDP-glucuronosyltransferase 1A1: Advances in understanding breast milk-induced neonatal hyperbilirubinemia. , 2015, Toxicology and applied pharmacology.
[20] Guangbo Ge,et al. Identification and characterization of naturally occurring inhibitors against UDP-glucuronosyltransferase 1A1 in Fructus Psoraleae (Bu-gu-zhi). , 2015, Toxicology and applied pharmacology.
[21] Liang Xu,et al. C-8 Mannich base derivatives of baicalein display improved glucuronidation stability: exploring the mechanism by experimentation and theoretical calculations , 2015 .
[22] M. Finel,et al. An optimized ratiometric fluorescent probe for sensing human UDP-glucuronosyltransferase 1A1 and its biological applications. , 2015, Biosensors & bioelectronics.
[23] Manjinder Singh,et al. Flavones: an important scaffold for medicinal chemistry. , 2014, European journal of medicinal chemistry.
[24] Michèle Rouleau,et al. Pharmacogenomics of Human Uridine Diphospho‐Glucuronosyltransferases and Clinical Implications , 2014, Clinical pharmacology and therapeutics.
[25] F. Ragab,et al. Design, synthesis and structure-activity relationship of novel semi-synthetic flavonoids as antiproliferative agents. , 2014, European journal of medicinal chemistry.
[26] F. Gonzalez,et al. Herb-drug interaction prediction based on the high specific inhibition of andrographolide derivatives towards UDP-glucuronosyltransferase (UGT) 2B7. , 2014, Toxicology and applied pharmacology.
[27] Jim Euchner. Design , 2014, Catalysis from A to Z.
[28] Jin Zhou,et al. Potential pharmacokinetic interactions of therapeutic cytokines or cytokine modulators on small-molecule drugs: mechanistic understanding via studies using in vitro systems , 2014, Drug metabolism and drug interactions.
[29] Wei Huang,et al. Efficient synthesis and antiproliferative activity of novel thioether-substituted flavonoids. , 2013, European journal of medicinal chemistry.
[30] Yan-Yan Zhang,et al. Deglycosylation of Liquiritin Strongly Enhances its Inhibitory Potential Towards UDP‐Glucuronosyltransferase (UGT) Isoforms , 2013, Phytotherapy research : PTR.
[31] N. Lu,et al. Oroxylin A induces dissociation of hexokinase II from the mitochondria and inhibits glycolysis by SIRT3-mediated deacetylation of cyclophilin D in breast carcinoma , 2013, Cell Death and Disease.
[32] Guangbo Ge,et al. The Inhibitory Effect of 20(S)‐Protopanaxatriol (ppt) Towards UGT1A1 and UGT2B7 , 2013, Phytotherapy research : PTR.
[33] Hyung Keun Kim,et al. Baicalin from Scutellaria baicalensis impairs Th1 polarization through inhibition of dendritic cell maturation. , 2013, Journal of pharmacological sciences.
[34] S. Zeng,et al. Roles of UDP-glucuronosyltransferases in phytochemical metabolism of herbal medicines and the associated herb-drug interactions. , 2012, Current drug metabolism.
[35] Xinxin Ding,et al. Quantitative distribution of mRNAs encoding the 19 human UDP-glucuronosyltransferase enzymes in 26 adult and 3 fetal tissues , 2012, Xenobiotica; the fate of foreign compounds in biological systems.
[36] Shuxing Zhang,et al. Evaluation of 3,3',4'-trihydroxyflavone and 3,6,4'-trihydroxyflavone (4'-O-glucuronidation) as the in vitro functional markers for hepatic UGT1A1. , 2011, Molecular pharmaceutics.
[37] J. Potter,et al. Determinants of Aspirin Metabolism in Healthy Men and Women: Effects of Dietary Inducers of UDP-Glucuronosyltransferases , 2011, Lifestyle Genomics.
[38] R. Frye,et al. Effects of herbal supplements on drug glucuronidation. Review of clinical, animal, and in vitro studies. , 2011, Planta medica.
[39] N. Oberlies,et al. Influence of dietary substances on intestinal drug metabolism and transport. , 2010, Current drug metabolism.
[40] G. Desideri,et al. Flavonoids: Antioxidants Against Atherosclerosis , 2010, Nutrients.
[41] Andrew G Mercader,et al. QSAR study of flavonoids and biflavonoids as influenza H1N1 virus neuraminidase inhibitors. , 2010, European journal of medicinal chemistry.
[42] Wei Liu,et al. Use of Isoform-Specific UGT Metabolism to Determine and Describe Rates and Profiles of Glucuronidation of Wogonin and Oroxylin A by Human Liver and Intestinal Microsomes , 2010, Pharmaceutical Research.
[43] Shuji Ohno,et al. Determination of mRNA Expression of Human UDP-Glucuronosyltransferases and Application for Localization in Various Human Tissues by Real-Time Reverse Transcriptase-Polymerase Chain Reaction , 2009, Drug Metabolism and Disposition.
[44] Shixuan Zhang,et al. Nitrogen-containing flavonoid analogues as CDK1/cyclin B inhibitors: synthesis, SAR analysis, and biological activity. , 2008, Bioorganic & medicinal chemistry.
[45] P. Ruzza,et al. Flavonoids diosmetin and luteolin inhibit midazolam metabolism by human liver microsomes and recombinant CYP 3A4 and CYP3A5 enzymes. , 2008, Biochemical pharmacology.
[46] V. Tam,et al. Disposition of flavonoids via enteric recycling: determination of the UDP-glucuronosyltransferase isoforms responsible for the metabolism of flavonoids in intact Caco-2 TC7 cells using siRNA. , 2007, Molecular pharmaceutics.
[47] I. Mcintosh,et al. Metabolism and Disposition in Humans of Raltegravir (MK-0518), an Anti-AIDS Drug Targeting the Human Immunodeficiency Virus 1 Integrase Enzyme , 2007, Drug Metabolism and Disposition.
[48] S. Mertens-Talcott,et al. Polymethoxylated flavones and other phenolic derivates from citrus in their inhibitory effects on P-glycoprotein-mediated transport of talinolol in Caco-2 cells. , 2007, Journal of agricultural and food chemistry.
[49] Andrew J Lamb,et al. Antimicrobial activity of flavonoids , 2005, International Journal of Antimicrobial Agents.
[50] C. Guillemette,et al. Nomenclature update for the mammalian UDP glycosyltransferase (UGT) gene superfamily. , 2005, Pharmacogenetics and genomics.
[51] J. Potter,et al. GLUCURONIDATION OF NONSTEROIDAL ANTI-INFLAMMATORY DRUGS: IDENTIFYING THE ENZYMES RESPONSIBLE IN HUMAN LIVER MICROSOMES , 2005, Drug Metabolism and Disposition.
[52] Tony K L Kiang,et al. UDP-glucuronosyltransferases and clinical drug-drug interactions. , 2005, Pharmacology & therapeutics.
[53] Barry C. Jones,et al. DRUG-DRUG INTERACTIONS FOR UDP-GLUCURONOSYLTRANSFERASE SUBSTRATES: A PHARMACOKINETIC EXPLANATION FOR TYPICALLY OBSERVED LOW EXPOSURE (AUCI/AUC) RATIOS , 2004, Drug Metabolism and Disposition.
[54] T. Goosen,et al. Silybin inactivates cytochromes P450 3A4 and 2C9 and inhibits major hepatic glucuronosyltransferases. , 2004, Drug metabolism and disposition: the biological fate of chemicals.
[55] P. Hollman. Absorption, Bioavailability, and Metabolism of Flavonoids , 2004 .
[56] Chi-Tang Ho,et al. Glucuronides of tea catechins: enzymology of biosynthesis and biological activities. , 2003, Drug metabolism and disposition: the biological fate of chemicals.
[57] R. Green,et al. Mechanism of indinavir-induced hyperbilirubinemia , 2001, Proceedings of the National Academy of Sciences of the United States of America.
[58] S. Wrighton,et al. The role of hepatic and extrahepatic UDP-glucuronosyltransferases in human drug metabolism*† , 2001, Drug metabolism reviews.
[59] E. Middleton,et al. The effects of plant flavonoids on mammalian cells: implications for inflammation, heart disease, and cancer. , 2000, Pharmacological reviews.
[60] G. Williamson,et al. Dietary intake and bioavailability of polyphenols. , 2000, The Journal of nutrition.
[61] H. Maeda,et al. Alkylperoxyl radical-scavenging activity of various flavonoids and other phenolic compounds: implications for the anti-tumor-promoter effect of vegetables. , 1999, Journal of agricultural and food chemistry.
[62] F. Fazio,et al. Errors Introduced by Tissue Heterogeneity in Estimation of Local Cerebral Glucose Utilization with Current Kinetic Models of the [18F]Fluorodeoxyglucose Method , 1992, Journal of cerebral blood flow and metabolism : official journal of the International Society of Cerebral Blood Flow and Metabolism.
[63] Alan Symmons,et al. ABSORPTION , 1981 .
[64] Richard Barnett. Diabetes , 1904, The Lancet.
[65] Aamir Ahmad,et al. Flavonoids-induced redox cycling of copper ions leads to generation of reactive oxygen species: A potential role in cancer chemoprevention. , 2018, International journal of biological macromolecules.
[66] Manisha J. Oza,et al. Diabetes, diabetic complications, and flavonoids , 2016 .
[67] J. Brockmöller,et al. Relevance of UDP-glucuronosyltransferase polymorphisms for drug dosing: A quantitative systematic review. , 2014, Pharmacology & therapeutics.
[68] A. Kunze. Prediction of human drug clearance and anticipation of clinical drug-drug interaction potential from in vitro drug transport studies , 2014 .
[69] S. Moro,et al. Flavonoids diosmetin and hesperetin are potent inhibitors of cytochrome P450 2C9-mediated drug metabolism in vitro. , 2010, Drug metabolism and pharmacokinetics.
[70] G. Rusak,et al. Structural aspects of flavonoids as inhibitors of human butyrylcholinesterase. , 2010, European journal of medicinal chemistry.
[71] E. Middleton. Effect of plant flavonoids on immune and inflammatory cell function. , 1998, Advances in experimental medicine and biology.